Prestige Consumer Healthcare (PBH) Net Cash Flow (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Net Cash Flow of -$57.0 million in Q4 2025, down 179.55% quarter-over-quarter from -$20.4 million in Q3 2025, and down 4142.91% on a YoY basis from $1.4 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Net Cash Flow (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$57.0 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 4142.91% year-over-year to -$57.0 million; the TTM figure through Dec 2025 stood at $10.3 million (up 189.88% YoY), while the FY2025 annual figure was $52.0 million, up 526.13% from the prior year.
- Net Cash Flow was -$57.0 million for Q4 2025 at Prestige Consumer Healthcare, down from -$20.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $131.6 million in Q2 2021 to a low of -$119.9 million in Q3 2021.
- Historically, Net Cash Flow has averaged $89700.0 across 5 years, with a median of $1.8 million in 2023.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow soared 439.6% in 2021, then slumped 4142.91% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$21.6 million in 2021, then surged by 299.9% to $43.1 million in 2022, then slumped by 95.05% to $2.1 million in 2023, then plunged by 33.9% to $1.4 million in 2024, then plunged by 4142.91% to -$57.0 million in 2025.
- The last three Net Cash Flow figures came in at -$57.0 million (Q4 2025), -$20.4 million (Q3 2025), and $40.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | -57.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.01 Mn |
| Dec 31, 2025 | -57.01 Mn |
| Sep 30, 2025 | -20.39 Mn |
| Sep 30, 2025 | -20.39 Mn |
| Jun 30, 2025 | 40.79 Mn |
| Jun 30, 2025 | 40.79 Mn |
| Mar 31, 2025 | 46.88 Mn |
| Mar 31, 2025 | 46.88 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 16.57 Mn |
| Sep 30, 2024 | 16.57 Mn |
| Jun 30, 2024 | -12.88 Mn |
| Jun 30, 2024 | -12.88 Mn |
| Mar 31, 2024 | -16.54 Mn |
| Mar 31, 2024 | -16.54 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | 5.98 Mn |
| Sep 30, 2023 | 5.98 Mn |